Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy-Reference-Cited by-同舟云学术

Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy

Published:2015-06 Issue:6 Volume:27 Page:852-863
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Han Bingshe,Park Dongkyoo,Li Rui,Xie Maohua,Owonikoko Taofeek K.,Zhang Guojing,Sica Gabriel L.,Ding Chunyong,Zhou Jia,Magis Andrew T.,Chen Zhuo G.,Shin Dong M.,Ramalingam Suresh S.,Khuri Fadlo R.,Curran Walter J.,Deng Xingming

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference57 articles.

1. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma;Aguirre;Apoptosis,2004

2. Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds;Bartel;J. Biol. Inorg. Chem.,2012

3. Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer;Besse;Ann. Oncol.,2014

4. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL;Bruncko;J. Med. Chem.,2007

5. A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation;Castelli;Cell Death Differ.,2004

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-06

2. Design, Synthesis, and in-silico Studies of New Disubstituted Benzimidazoles: Evaluation of In-vitro Anticancer and Antimicrobial Activity;INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY;2024-03

4. ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia;Nature Communications;2023-09-19

5. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth;BMC Cancer;2023-05-26